Mcl-1 is the primary anti-apoptosis protein overexpressed in various NSCLC, implying that Mcl-1 inhibition could lead to more successful targeted therapy for lung cancer [15]. This evidence concerns the gene MCL1 and non-small cell lung carcinoma.